Compounds > nialamide
Page last updated: 2024-11-01

nialamide and Syndrome

nialamide has been researched along with Syndrome in 2 studies

Nialamide: An MAO inhibitor that is used as an antidepressive agent.

Syndrome: A characteristic symptom complex.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FLOREZ TASCON, FJ1
CONSTAIN MOSQUERA, C1
GONZALEZ PARRA, A1

Other Studies

2 other studies available for nialamide and Syndrome

ArticleYear
[Metabolic craneopathy and antidepressive therapeutics. (Neuroendocrine endocranial hyperostotic syndrome (N.E.H.S.) or Morgagni-Stewart-Morel-Pende syndrome and nialamide].
    Revista clinica espanola, 1960, Mar-31, Volume: 76

    Topics: Depression; Humans; Hyperostosis Frontalis Interna; Iproniazid; Nialamide; Syndrome

1960
[PRELIMINARY REPORT ON THE USE OF AN ENZYME INHIBITOR (NIALAMIDE) IN ORGANIC MENTAL SYNDROMES IN THE AGED].
    Revista de investigacion, 1964, Volume: 4

    Topics: Drug Therapy; Enzyme Inhibitors; Geriatrics; Intracranial Arteriosclerosis; Mental Disorders; Nialam

1964